In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Editorial: Will Next Anti-Aging Market Disruptor Be Anti-Anti-Aging?

This article was originally published in The Rose Sheet

Executive Summary

"The Rose Sheet" makes a case for the theoretical Dollar Anti-Aging Club and why updating the FDCA's "cosmetic" definition as part of broader regulatory reform could be in industry's interest.


Related Content

Any More Athenas Out There? Plaintiffs May Allege So In Expected Suits
Supreme Court Turns Down Athena v. Allergan; 'Torrent' Of Suits To Come?
Gillette Works To Promote Razor Science, Male Underarm Shaving
House Cosmetics Bill Imminent With Small – And Big – Business Support
Aligning U.S. With EU Cosmetic Definition Could Enable Claims, Reduce FDA Warnings
FDA Warns Lancome For Gene/Stem-Cell Claims: A Signal To Marketplace?



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts